Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-13

Clinical Trial Update: Tobradex as Intracanal Medicament [NA]

View source ↗

Summary

Completed clinical trial evaluating Tobradex as an intracanal medicament for symptomatic irreversible pulpitis and postoperative endodontic pain after emergency…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tobradex (tobramycin and dexamethasone)

Snippet

Sponsor: Umm Al-Qura University | Conditions: Symptomatic Irreversible Pulpitis, Postoperative Endodontic Pain Following Emergency Root Canal Treatment | NA | Status: COMPLETED